ASCT Benefited Younger, Older Multiple Myeloma Patients Equally, Study Finds
Multiple myeloma patients older than 65 years benefit as…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Alkeran-based 4-drug Combo Gives Excellent Outcomes in Myeloma Patients Undergoing Transplants
A combination treatment of four drugs including the chemotherapy…
Revlimid for Myeloma After Stem Cell Transplant Gets Nod from EMA Panel
The use of Revlimid (lenalidomide) as a maintenance…
Combo Therapy After Stem Cell Transplant Improves Survival in Myeloma Patients, Trial Finds
Combination treatment with Velcade (bortezomib) and Thalomid (thalidomide) may…
Cellectar’s Patent for Anti-cancer Compounds Includes Potential Myeloma Therapy
Cellectar Biosciences has been granted a U.S. patent for…
Longer Dosing Interval of Zoledronic Acid Found Acceptable for Bone Metastasis
Patients with bone metastasis due to multiple myeloma, breast or prostate cancer, who received…
